https://www.selleckchem.com/pr....oducts/itacitinib-in
46 mmHg [95%CI -2.63, -0.28; P = 0.01]) with no heterogeneity (P = 0.46; I = 0%). Serum lipopolysaccharide-binding protein (LBP) significantly decreased with antibiotics, but with high heterogeneity (P0.001; I = 92%). Rifaximin or norfloxacin did not significantly reduce HVPG in patients with cirrhosis and portal hypertension. Studies using antibiotic for longer periods on top of NSBB showed a significant decrease in HVPG. Rifaximin or norfloxacin did not significantly reduce HVPG in patients with cirrhosis and portal
Like
Comment
Share
